Dario Amodei Says Public Distrust of AI Runs Deeper Than Any CEO's Messaging

Dario Amodei, CEO of Anthropic, fired back this week at suggestions that his cautious public stance on artificial intelligence has fueled negative sentiment toward the industry. The dispute was sparked by investor Gavin Baker, who argued on the All-In podcast and on X that Amodei's repeated warnings about AI dangers have contributed to a backlash in the United States, including growing opposition to data center construction. Baker went further, telling Amodei that, as the prospective leader of one of the world's most consequential companies, he should work harder to be a positive advocate for the field.

Amodei rejected the framing. In a series of posts, he argued that his writing has been balanced between risks and benefits, citing his essay 'Machines of Loving Grace' as an example of work specifically intended to articulate AI's transformative potential — something he felt the broader industry was failing to communicate. He also noted that Anthropic has actively pushed for regulation, including backing a California bill requiring transparency from large AI companies, though he framed those proposals as deliberately designed to constrain frontier AI companies while giving smaller competitors more room to operate.

On the question of public opinion, Amodei did not dismiss the problem. He agreed that broad negativity toward AI is real and significant. But he placed the root cause much further back in history, describing the current moment as 'fundamentally a crisis of trust' stemming from decades of ordinary people feeling that corporations, governments, and the tech sector were working against their interests. In his view, the AI backlash is simply the latest chapter in that longer story.

Amodei's sharpest self-criticism was directed at the gap between AI's promises and its actual delivered benefits. He said the most accurate critique of Anthropic and its peers is that they have not yet made good on their grandest claims, whether that means curing diseases or meaningfully improving lives at scale. Promising to cure cancer, he wrote, has become 'more a cliche than it is inspiring'; what would genuinely shift public opinion is the act of actually doing it.

On regulation, Amodei pushed back against what he called Silicon Valley's tendency to treat any oversight as a path toward regulatory capture and power concentration. He argued that thoughtful rules could simultaneously reduce AI's cybersecurity and biosecurity risks, limit the institutional power of frontier AI labs, and leave space for open-weight models — while also addressing the risks those models introduce, particularly around access to compute and chips.